Targeting High risk populations for HPV associated cancers (cervix, anus, OP): from risk assessment to control of diseases

• MSS 05-01 • Defining the population at risk: epidemiological, geographical and societal markers See abstract > S. Silvia Franceschi • MSS 05-02 • Cytohistologic indicators See abstract > M. Mark STOLER • MSS 05-03 • Virological markers > P. Patti GRAVITT • MSS 05-04 • HPV genetic variation See abstract > L. Lisa MIRABELLO • MSS 05-05 • Cervical and penile immune profiling data from (matched) primary tumors and lymph nodes > E. Ekaterina JORDANOVA • MSS 05-06 • Which screening is the best approach? See abstract > N. Nicolas Wentzensen • MSS 05-07 • Expected impact of immunization in high risk population at all ages > X. Xavier BOSCH